** Shares of medical device coatings maker Surmodics
SRDX.O rise 20.8% to ~$42 before the bell
** Co enters into an agreement to be acquired by private
equity firm GTCR for a total equity value of about $627 mln
** GTCR will acquire all outstanding shares of SRDX for
$43.00 per share in cash, which represents a premium of more
than 22% to the stock's last close
** Upon completion of the transaction, expected in the
second half of 2024, Surmodics will be a privately held company
** AS of last close, stock was down 3.4% YTD
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))